Product Information
PENTAZOCINE-NALOXONE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $2.0202 per EA under NDC 00591039501. Its NADAC has been published 571 times since Nov 28, 2013.
Strength
.5; 50 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591039501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074736On Market Since
5/21/1997
Pharmacological Classes
Price Statistics
The NADAC for PENTAZOCINE-NALOXONE TABLET has been published 571 times since Nov 28, 2013, and over the history we have for it it has risen 100.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0202 per EA |
|---|---|
| All-time high | $2.1945 (Aug 12, 2015) |
| All-time low | $1.0089 (Nov 28, 2013) |
| 52-week high | $2.0202 |
| 52-week low | $1.7158 |
| Median price | $1.9141 |
| Average price | $1.8470 |
| Largest weekly change | +61.0% (Aug 20, 2014) |
| Weeks tracked | 571 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pentazocine hydrochloride and naloxone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PENTAZOCINE-NALOXONE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PENTAZOCINE-NALOXONE TABLET, manufactured by Actavis Pharma, Inc., is $2.0202 per EA (NDC 00591039501), effective Jun 24, 2026.
How has the price of PENTAZOCINE-NALOXONE TABLET changed over time?
Over the history we have for it, the NADAC for PENTAZOCINE-NALOXONE TABLET has risen 100.2%. It has been tracked across 571 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PENTAZOCINE-NALOXONE TABLET?
Since Nov 28, 2013, the NADAC for PENTAZOCINE-NALOXONE TABLET has ranged from a low of $1.0089 (Nov 28, 2013) to a high of $2.1945 (Aug 12, 2015), with a median of $1.9141 per EA.
Are there cheaper alternatives to PENTAZOCINE-NALOXONE TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PENTAZOCINE-NALOXONE TABLET, so no direct lower-cost alternative is listed.
Who manufactures PENTAZOCINE-NALOXONE TABLET?
PENTAZOCINE-NALOXONE TABLET (NDC 00591039501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification